IRIDEX CFO buys 1,110 shares in open market
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
IRIDEX Corp’s Chief Financial Officer, Romeo R. Dizon, reported an open-market purchase of company stock. On March 6, 2026, he bought 1,110 shares of IRIDEX common stock at $1.26 per share. Following this transaction, his direct holdings increased to 121,000 shares.
Insider Trade Summary
Net Buyer: 1,110 shares
Net Buy
1 txn
Insider
Dizon Romeo R
Role
Chief Financial Officer
Bought
1,110 shs ($1K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 1,110 | $1.26 | $1K |
Holdings After Transaction:
Common Stock — 121,000 shares (Direct)
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IRIDEX (IRIX) disclose for Romeo R. Dizon?
IRIDEX disclosed that CFO Romeo R. Dizon bought 1,110 common shares. The shares were acquired in an open-market purchase at $1.26 per share, increasing his direct holdings to 121,000 shares after the transaction.
Was the IRIDEX (IRIX) CFO’s Form 4 transaction a buy or a sell?
The Form 4 reports a buy transaction by the IRIDEX CFO. Romeo R. Dizon executed an open-market purchase of 1,110 shares of common stock at a price of $1.26 per share, increasing his direct ownership.
What type of transaction is reported in IRIDEX (IRIX) CFO’s Form 4?
The Form 4 reports an open-market purchase of common stock. CFO Romeo R. Dizon acquired 1,110 IRIDEX shares at $1.26 per share, and the filing classifies the trade as a non-derivative, direct ownership transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.